Chelonae infections associated with tattooing in France.5 In that outbreak, M. Chelonae was isolated in 13 patients; no PFGE evaluation was performed. M. Chelonae was isolated from opened, however, not unopened, bottles of ink. In the usa, Drage et al. Described an outbreak of M. Chelonae infections involving 6 patients with tattoos.4 In that full case series, cultures confirmed M. Chelonae infections in 3 patients. Previous studies, although not testing designed for mycobacteria, show that unopened stock bottles of tattoo ink may contain bacteria that are pathogenic in humans despite claims of sterility.25 In the current study, mycobacteria had been detected in both opened and unopened bottles of ink.Further, the consequences of ALN-RSV01 on day time 180 BOS persisted when controlled for the concomitant administration of pulse-dosage steroids. A direct comparison of individuals getting ALN-RSV01 in the absence of ribavirin versus placebo sufferers getting inhaled ribavirin, the current standard of care at some centers, demonstrated that ALN-RSV01 was connected with a statistically significant reduction in brand-new or progressive BOS at day 180 . There is an identical incidence of reported adverse occasions in placebo and study drug treatment arms. Significant adverse events were also reported with comparable incidence in sufferers getting placebo and ALN-RSV01 . In aggregate, the recently presented results support the conclusion that treatment of RSV-infected lung transplant individuals with ALN-RSV01 is generally safe and well tolerated and connected with a reduced incidence of new or progressive BOS.